These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 23188784

  • 41. Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis.
    Shan CX, Zhang W, Jiang DZ, Zheng XM, Liu S, Qiu M.
    Laryngoscope; 2012 Apr; 122(4):797-804. PubMed ID: 22294492
    [Abstract] [Full Text] [Related]

  • 42. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
    Ito Y, Miyauchi A, Masuoka H, Fukushima M, Kihara M, Miya A.
    World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer.
    Wang TS, Cheung K, Farrokhyar F, Roman SA, Sosa JA.
    Ann Surg Oncol; 2013 Oct; 20(11):3477-83. PubMed ID: 23846784
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: An updated meta-analysis.
    Zhao WJ, Luo H, Zhou YM, Dai WY, Zhu JQ.
    Eur J Surg Oncol; 2017 Nov; 43(11):1989-2000. PubMed ID: 28807633
    [Abstract] [Full Text] [Related]

  • 48. Local lymph node recurrence after central neck dissection in papillary thyroid cancers: A meta analysis.
    Liu H, Li Y, Mao Y.
    Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Nov; 136(6):481-487. PubMed ID: 31196800
    [Abstract] [Full Text] [Related]

  • 49. Prophylactic Central Neck Lymph Node Dissection in Low-risk Thyroid Carcinoma Patients Does Not Decrease the Incidence of Locoregional Recurrence: A Meta-analysis of Randomized Trials.
    Sanabria A, Betancourt-Agüero C, Sánchez-Delgado JG, García-Lozano C.
    Ann Surg; 2022 Jul 01; 276(1):66-73. PubMed ID: 35129470
    [Abstract] [Full Text] [Related]

  • 50. Low-risk papillary thyroid cancer recurrence in patients treated with total thyroidectomy and adjuvant therapy vs. patients treated with partial thyroidectomy.
    Hurtado-López LM, Melchor-Ruan J, Basurto-Kuba E, Montes de Oca-Durán ER, Pulido-Cejudo A, Athié-Gutiérrez C.
    Cir Cir; 2011 Jul 01; 79(2):118-25. PubMed ID: 21631972
    [Abstract] [Full Text] [Related]

  • 51. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma.
    Pereira JA, Jimeno J, Miquel J, Iglesias M, Munné A, Sancho JJ, Sitges-Serra A.
    Surgery; 2005 Dec 01; 138(6):1095-100, discussion 1100-1. PubMed ID: 16360396
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Long-term oncologic outcome of robotic versus open total thyroidectomy in PTC: a case-matched retrospective study.
    Lee SG, Lee J, Kim MJ, Choi JB, Kim TH, Ban EJ, Lee CR, Kang SW, Jeong JJ, Nam KH, Jo YS, Chung WY.
    Surg Endosc; 2016 Aug 01; 30(8):3474-9. PubMed ID: 26514137
    [Abstract] [Full Text] [Related]

  • 57. Staged Surgery for Advanced Thyroid Cancers: Safety and Oncologic Outcomes of Neural Monitored Surgery.
    Salari B, Hammon RJ, Kamani D, Randolph GW.
    Otolaryngol Head Neck Surg; 2017 May 01; 156(5):816-821. PubMed ID: 28374646
    [Abstract] [Full Text] [Related]

  • 58. [Salvage central neck dissection for papillary thyroid cancer].
    Yu WB, Song YT, Zhang NS.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct 01; 47(10):823-6. PubMed ID: 23302163
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. BRAF mutation in papillary thyroid cancer: A cost-utility analysis of preoperative testing.
    Lee WS, Palmer BJ, Garcia A, Chong VE, Liu TH.
    Surgery; 2014 Dec 01; 156(6):1569-77; discussion 1577-8. PubMed ID: 25444226
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.